Acadian Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.69M | Buy |
6,549,687
+3,904,498
| +148% | +$2.79M | 0.01% | 602 |
|
|
2025
Q1 | $3.88M | Buy |
2,645,189
+1,630,726
| +161% | +$2.39M | 0.01% | 577 |
|
|
2024
Q4 | $4.49M | Buy |
1,014,463
+228,171
| +29% | +$1.01M | 0.01% | 552 |
|
|
2024
Q3 | $3.24M | Buy |
+786,292
| New | +$3.24M | 0.01% | 611 |
|
|
2022
Q4 | – | Sell |
-5,562
| Closed | -$57K | – | 1848 |
|
|
2022
Q3 | $57K | Hold |
5,562
| – | – | ﹤0.01% | 1477 |
|
|
2022
Q2 | $64K | Sell |
5,562
-446
| -7% | -$5.13K | ﹤0.01% | 1454 |
|
|
2022
Q1 | $75K | Sell |
6,008
-9,721
| -62% | -$121K | ﹤0.01% | 1418 |
|
|
2021
Q4 | $183K | Sell |
15,729
-289,128
| -95% | -$3.36M | ﹤0.01% | 1257 |
|
|
2021
Q3 | $3.98M | Sell |
304,857
-363,304
| -54% | -$4.74M | 0.02% | 512 |
|
|
2021
Q2 | $8.6M | Buy |
668,161
+443,525
| +197% | +$5.71M | 0.03% | 345 |
|
|
2021
Q1 | $2.51M | Sell |
224,636
-460,255
| -67% | -$5.14M | 0.01% | 670 |
|
|
2020
Q4 | $7.8M | Sell |
684,891
-110,913
| -14% | -$1.26M | 0.03% | 393 |
|
|
2020
Q3 | $7.16M | Buy |
795,804
+281,472
| +55% | +$2.53M | 0.03% | 368 |
|
|
2020
Q2 | $5.31M | Buy |
514,332
+512,383
| +26,290% | +$5.29M | 0.02% | 472 |
|
|
2020
Q1 | $20K | Buy |
+1,949
| New | +$20K | ﹤0.01% | 1646 |
|